 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: IONIS-FXI-LRx
                                 Compound class: 
                                                            Nucleic acid
                                 
                                    
                                        Comment: Fesomersen (IONIS-FXI-LRx) is a conjugated antisense oligonucleotide that selectively inhibits the expression of factor XI [1]. It is being explored as an anticoagulation therapy. We provide the basic nucleotide sequence, without the modifications outlined in the INN record for this drug. | 
| Classification  | |
| Compound class | Nucleic acid | 
| Compound subclass | Antisense oligonucleotide (ASO) | 
| Target | Factor XI | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 11638 | fesomersen | 
| Synonyms  | 
| IONIS-FXI-LRx | 
| Database Links  | |
| CAS Registry No. | 2380135-03-3 (source: WHO INN record) | 
| GtoPdb PubChem SID | 518520708 | 
| Search PubMed clinical trials | fesomersen | 
| Search PubMed titles | fesomersen | 
| Search PubMed titles/abstracts | fesomersen |